Toronto, Canada

Jahangir Tavakkoli

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jahangir Tavakkoli: Innovator in Cancer Imaging and Treatment

Introduction

Jahangir Tavakkoli is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of cancer treatment and imaging. His innovative approaches aim to enhance the effectiveness of cancer therapies through advanced technology.

Latest Patents

Tavakkoli holds a patent for "Cancer imaging methods and cancer treatment methods using thermotherapy and drug delivery." This patent outlines several embodiments that utilize radio-frequency data from ultrasound transducers to determine the temperature of heated tissue. Additionally, it describes the administration of nanocarriers containing anti-tumor medication, which can be excited using ultrasound sources. The patent also includes methods for heating nanoparticles at tumor sites and using photoacoustic imaging to assess tissue temperature.

Career Highlights

Throughout his career, Tavakkoli has focused on developing innovative solutions for cancer treatment. His work has the potential to improve patient outcomes by integrating thermotherapy with drug delivery systems. He is associated with Cancer Rx, LLC, where he continues to advance his research and development efforts.

Collaborations

Tavakkoli has collaborated with esteemed colleagues such as Gholam A Peyman and Michael Kolios. These partnerships have fostered a collaborative environment that enhances the research and development of cancer treatment technologies.

Conclusion

Jahangir Tavakkoli is a pioneering inventor whose work in cancer imaging and treatment showcases the potential of innovative technologies in healthcare. His contributions are paving the way for more effective cancer therapies and improved patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…